HK1080449A1 - 抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物 - Google Patents

抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物

Info

Publication number
HK1080449A1
HK1080449A1 HK06100260.7A HK06100260A HK1080449A1 HK 1080449 A1 HK1080449 A1 HK 1080449A1 HK 06100260 A HK06100260 A HK 06100260A HK 1080449 A1 HK1080449 A1 HK 1080449A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
inflammatory agent
cetylpyridinium salt
cetylpyridinium
Prior art date
Application number
HK06100260.7A
Other languages
English (en)
Inventor
Giorgio Pifferi
Original Assignee
方濟各安吉利克化學聯合股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 方濟各安吉利克化學聯合股份有限公司 filed Critical 方濟各安吉利克化學聯合股份有限公司
Publication of HK1080449A1 publication Critical patent/HK1080449A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18—Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06100260.7A 2003-02-14 2006-01-06 抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物 HK1080449A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio
PCT/EP2004/001412 WO2004072017A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
HK1080449A1 true HK1080449A1 (zh) 2006-04-28

Family

ID=32866065

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100260.7A HK1080449A1 (zh) 2003-02-14 2006-01-06 抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物

Country Status (16)

Country Link
US (1) US7250428B2 (zh)
EP (1) EP1592657A1 (zh)
JP (1) JP2006517565A (zh)
KR (1) KR20050101186A (zh)
CN (1) CN1318389C (zh)
AR (1) AR043171A1 (zh)
AU (1) AU2004212154A1 (zh)
CA (1) CA2511900A1 (zh)
EA (1) EA008003B1 (zh)
GE (1) GEP20064009B (zh)
HK (1) HK1080449A1 (zh)
IL (1) IL169312A (zh)
IT (1) ITMI20030269A1 (zh)
MX (1) MXPA05008589A (zh)
PL (1) PL376362A1 (zh)
WO (1) WO2004072017A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US20120178769A1 (en) * 2009-07-15 2012-07-12 The University Of Medicine And Dentistry Novel compounds for inhibiting eef-2 kinase activity
KR101666659B1 (ko) * 2014-06-12 2016-10-14 한국생명공학연구원 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
IT1228242B (it) * 1986-11-13 1991-06-05 Ricerfarma Srl Milano Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono
IT1250636B (it) * 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
DE69533105T2 (de) * 1994-06-06 2005-06-09 The Jmde Trust, Newton Biotinverbindungen zum zielen auf tumore und infektionsherde
DE19856101A1 (de) * 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
JP2000256186A (ja) 1999-03-05 2000-09-19 Taisho Pharmaceut Co Ltd 咽頭疾患用組成物

Also Published As

Publication number Publication date
CN1745061A (zh) 2006-03-08
ITMI20030269A1 (it) 2004-08-15
IL169312A0 (en) 2007-07-04
IL169312A (en) 2010-05-17
CA2511900A1 (en) 2004-08-26
US7250428B2 (en) 2007-07-31
AR043171A1 (es) 2005-07-20
KR20050101186A (ko) 2005-10-20
US20060142353A1 (en) 2006-06-29
MXPA05008589A (es) 2005-11-04
EA008003B1 (ru) 2007-02-27
CN1318389C (zh) 2007-05-30
WO2004072017A1 (en) 2004-08-26
EA200501088A1 (ru) 2005-12-29
GEP20064009B (en) 2006-12-25
PL376362A1 (en) 2005-12-27
JP2006517565A (ja) 2006-07-27
AU2004212154A1 (en) 2004-08-26
EP1592657A1 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
HK1213802A1 (zh) 施用 激動劑的方法和組合物
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL163931A (en) Derivatives of Tetrazycline Compounds Converted by Amino Methyl and Pharmaceutical Preparation Containing Them
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
EP1660043A4 (en) FORMULATION WITH IMMEDIATE RELEASE OF ACID ELASTIC PHARMACEUTICAL COMPOSITIONS
SI1354873T1 (en) Salt of perindopril and pharmaceutical compositions containing it
IL165591A0 (en) Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents pharmaceutical compositions including the same and methods fortheir use
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
EP1765379A4 (en) CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL173639A (en) Ppar-activating compound and pharmaceutical composition containing same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
ZA200508204B (en) Pharmaceutical composition of atorvastatin
HK1082677A1 (en) Androgen pharmaceutical composition and use for manufacture of medicament
IL174144A0 (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same